{
    "id": 1218,
    "fullName": "ERBB3 act mut",
    "impact": "unknown",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ERBB3 (HER3) act mut indicates that this variant results in a gain of function in the Erbb3 (Her3) protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 2065,
        "geneSymbol": "ERBB3",
        "terms": [
            "ERBB3",
            "c-erbB-3",
            "c-erbB3",
            "ErbB-3",
            "erbB3-S",
            "FERLK",
            "HER3",
            "LCCS2",
            "MDA-BF-1",
            "p180-ErbB3",
            "p45-sErbB3",
            "p85-sErbB3"
        ]
    },
    "variant": "act mut",
    "createDate": "07/31/2014",
    "updateDate": "04/25/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11931,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Tykerb (lapatinib) inhibited proliferation and colony formation in transformed cell lines expressing ERBB3 (HER3) activating mutations (PMID: 23680147).",
            "molecularProfile": {
                "id": 1242,
                "profileName": "ERBB3 act mut"
            },
            "therapy": {
                "id": 787,
                "therapyName": "Lapatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 323,
                    "pubMedId": 23680147,
                    "title": "Oncogenic ERBB3 mutations in human cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23680147"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2933,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing ERBB3 (HER3) activating mutations demonstrated sensitivity to Nerlynx (neratinib), resulting in inhibition of Erbb3 (Her3) phosphorylation, downstream signaling, and cell growth (Cancer Res October 1, 2014 74; 3419).",
            "molecularProfile": {
                "id": 1242,
                "profileName": "ERBB3 act mut"
            },
            "therapy": {
                "id": 828,
                "therapyName": "Neratinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3538,
                    "pubMedId": null,
                    "title": "Abstract 3419: Frequency and function of ERBB3 mutations in bladder cancer",
                    "url": "http://cancerres.aacrjournals.org/content/74/19_Supplement/3419.abstract"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1242,
            "profileName": "ERBB3 act mut",
            "profileTreatmentApproaches": [
                {
                    "id": 14785,
                    "name": "HER2 Inhibitor",
                    "profileName": "ERBB3 act mut"
                },
                {
                    "id": 14789,
                    "name": "Trastuzumab",
                    "profileName": "ERBB3 act mut"
                },
                {
                    "id": 14787,
                    "name": "HER3 Inhibitor",
                    "profileName": "ERBB3 act mut"
                },
                {
                    "id": 14788,
                    "name": "Pertuzumab",
                    "profileName": "ERBB3 act mut"
                },
                {
                    "id": 14786,
                    "name": "HER inhibitor (Pan)",
                    "profileName": "ERBB3 act mut"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}